Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference49 articles.
1. Sleire L, Førde HE, Netland IA, Leiss L, Skeie BS, Enger PØ. Drug repurposing in cancer. Pharmacol Res. 2017;124:74–91. https://doi.org/10.1016/j.phrs.2017.07.013.
2. Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, et al. Drug resistance in cancer: an overview. Cancers. 2014;6(3):1769–92. https://doi.org/10.3390/cancers6031769.
3. Padala SA, Kallam A. Diffuse large B-cell lymphoma. In: StatPearls. Treasure Island: StatPearls Publishing; 2023 [cited 2023 Jun 15]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK557796/.
4. Carreras J, Hiraiwa S, Kikuti YY, Miyaoka M, Tomita S, Ikoma H, et al. Artificial neural networks predicted the overall survival and molecular subtypes of diffuse large B-cell lymphoma using a pancancer immune-oncology panel. Cancers. 2021;13(24):6384. https://doi.org/10.3390/cancers13246384.
5. Carreras J, Roncador G, Hamoudi R. Artificial intelligence predicted overall survival and classified mature B-cell neoplasms based on immuno-oncology and immune checkpoint panels. Cancers. 2022;14(21):5318. https://doi.org/10.3390/cancers14215318.